Psychedelic medicine is making a comeback

Interview with Dr. Matthew Johnson, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. Renewed interest in the use of psychedelic drugs as treatments for illnesses such as anxiety, addiction and post-traumatic stress disorder has led to small controlled studies. In association with psychotherapy some psychedelic drugs have shown good effects with adequate safety. In an analysis article published in CMAJ, Dr. Johnson and colleagues look at new emerging evidence. Full article: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.141124To request a transcript of this podcast, contact cmajgroup@cmaj.ca-----------------------------------Subscribe to CMAJ Podcasts on iTunes or your favourite podcast app. You can also follow us directly on our SoundCloud page. Our podcasts are also released on www.cmaj.ca.

Comments or questions? Text us.

Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.

You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole

X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca

The CMAJ Podcast is produced by PodCraft Productions